Recent News

• 12.05.2025 - Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
• 12.05.2025 - Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million
• 12.02.2025 - Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
• 12.02.2025 - Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs
• 11.12.2025 - Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
• 11.12.2025 - Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
• 11.07.2025 - Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
• 11.07.2025 - Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
• 10.07.2025 - Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial
• 10.07.2025 - Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

Recent Filings

• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.12.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 8-K Current report
• 11.06.2025 - 8-K Current report
• 10.22.2025 - 8-K Current report
• 10.16.2025 - 8-K Current report
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities